Drug recall D-0729-2026
Product
Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-57; NDC Vial: 63323-485-03
Reason for recall
Presence of Particulate Matter: Hair was found in products
Lots and codes
Lot #: 6133986, Exp. Date 02/2029
Recall details
- Recalling firm
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Quantity
- 37,250 vials
- Distribution
- Nationwide within in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 16, 2026
Related products
- Xylocaine – drug information
- NDC 63323-484 Xylocaine · Lidocaine Hydrochloride Anhydrous 5 mg/mL · Fresenius Kabi USA, LLC
- NDC 63323-492 Xylocaine MPF · Lidocaine Hydrochloride Anhydrous 10 mg/mL · Fresenius Kabi USA, LLC
- NDC 63323-483 Xylocaine · Lidocaine Hydrochloride Anhydrous 20 mg/mL; Epinephrine… · Fresenius Kabi USA, LLC
- NDC 63323-487 Xylocaine MPF · Lidocaine Hydrochloride Anhydrous 10 mg/mL; Epinephrine… · Fresenius Kabi USA, LLC
- NDC 63323-489 Xylocaine MPF · Lidocaine Hydrochloride Anhydrous 20 mg/mL; Epinephrine… · Fresenius Kabi USA, LLC
- NDC 63323-495 Xylocaine MPF · Lidocaine Hydrochloride Anhydrous 20 mg/mL · Fresenius Kabi USA, LLC
- NDC 63323-481 Xylocaine · Lidocaine Hydrochloride Anhydrous 5 mg/mL; Epinephrine… · Fresenius Kabi USA, LLC
- NDC 63323-485 Xylocaine · Lidocaine Hydrochloride Anhydrous 10 mg/mL · Fresenius Kabi USA, LLC
- NDC 63323-488 Xylocaine MPF · Lidocaine Hydrochloride Anhydrous 15 mg/mL; Epinephrine… · Fresenius Kabi USA, LLC
- NDC 63323-482 Xylocaine · Lidocaine Hydrochloride Anhydrous 10 mg/mL; Epinephrine… · Fresenius Kabi USA, LLC
- NDC 63323-486 Xylocaine · Lidocaine Hydrochloride Anhydrous 20 mg/mL · Fresenius Kabi USA, LLC
- NDC 63323-491 Xylocaine MPF · Lidocaine Hydrochloride Anhydrous 5 mg/mL · Fresenius Kabi USA, LLC